Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial
Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page
- Check4 days agoChange DetectedEnrollment status updated to indicate recruitment is closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page also shows a revision to v3.6.0 and a removal of the Intervention/Treatment label, reflecting content restructuring.SummaryDifference0.2%

- Check11 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, indicating a page patch has been applied. This reflects an internal versioning update rather than a change to the study content or user-facing features.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedA new PubMed citation has been added to Publications for DESTINY-PanTumor02, describing antitumor activity and biomarker analyses in HER2-expressing gynecologic cancers. This expands the study's related literature tied to the trial without changing any study details.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision: v3.5.4 has been added, replacing Revision: v3.5.3. This reflects an update to the site's versioning metadata and does not change the study details.SummaryDifference0.0%

- Check40 days agoChange DetectedNothing changed according to the provided changes data. There are no additions or deletions to interpret, so the page content remains as published.SummaryDifference0.0%

- Check47 days agoChange DetectedThe Taiwan site entry has been updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333. This change clarifies the city designation while preserving the postal code.SummaryDifference0.0%

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.